MDR & Clinical Investigation | 디엔에이테크퍼시픽-DNA TECHNOLOGIES PACIFIC                        
DNA Technologies Pacific

ring_volume  Phone : +82 2 6749-1161

forward_to_inbox  E-mail : info@dna-tec.org

Search in Boards

사이트 내 전체검색

Clinical Research

CS Center

Tel. 02-6749-1161

AM 9:00 ~ PM 6:00

* Saturday,Sunday,Holiday : Days Off

Fax 02.6749.0711
info@dna-tec.org

MDR & Clinical Investigation


❉ ❉ ❉

MDR and Clinical Investigation



The MDR requires enhanced processes for data and evaluation of clinical investigation. The manufacturers shall provide clinical evaluation reports to demonstrate the safety and performance of the medical device.



MDR and Clinical Investigation

  • 1. The following considerations should be taken into account when conducting a clinical evaluation

    -  Class III and Class IIb products shall carry out clinical investigations.
    -  Class III and Class IIb devices are subject to inclusion of clinical evaluation user manuals and PMCF plans.
    -  Manufacturers require expert consultation on clinical evaluation and clinical research.


  • 2. Procedure for obtaining clinical data is as follows.

    -  Data collection on clinical experience of equivalent medical devices.
    -  Deriving clinical results through clinical research reports.
    -  Clinical investigation using similar devices.


  • 3. Clinical assessment should follow one of the following procedures.

    -  Evaluation of scientific literature that assesses design characteristics, stability, and performance of medical devices as they demonstrate equivalence with relevant devices and comply with requirements.
    -  Clinical Evaluation considering alternative treatments currently used.


The clinical evaluation shall be updated with the validity period of the medical device, with clinical data carried out under the PMCF plan referred to in Annex XV Part B and 84 of MDR. For CLASS III and CLASS IIB implantable devices, the PMCF report shall be updated annually, and a summary of the safety and performance of medical devices will be uploaded to the EUDAMED and updated annually.

DNA TECHNOLOGIES PACIFIC Business

  • 01Safety and efficacy clinical trials for CE certification of medical devices

  • 02PMCF progress on CE certified medical devices

  • 03Support the PMCF Plan, Protocol, and Investigator's Brochure

  • 04Collect health and economic data to obtain approval for reimbursement

  • 05System and product certification technical support

CRO



CRO (Contract Research Organization) means a person or institution delegated by contract to represent a client's role in relation to a clinical evaluation.
The CROs in EU member states shall, in some cases, perform their duties after obtaining approval under the CRO work from the relevant authority bodies for medical devices.



CRO

  • 1. DNA Technologies Pacific, supports CRO services for medical device manufacturers in Asia and the Pacific.

    -  Support for the preparation of PMCF Plan
    -  Support for clinical Investigations Synopsis and Protocol creation
    -  Support the creation of Investigator's Brochure
    -  Management of clinical Investigations in Europe
    -  Clinical Data Management
    -  Performs EU Representative
    -  Performs market exploration support

DNA TECHNOLOGIES PACIFIC Business

  • 01Safety and efficacy clinical trials for CE certification of medical devices

  • 02PMCF progress on CE certified medical devices

  • 03Support the PMCF Plan, Protocol, and Investigator's Brochure

  • 04Collect health and economic data to obtain approval for reimbursement

  • 05System and product certification technical support

Quick Menu